1. Home
  2. ZVRA vs INN Comparison

ZVRA vs INN Comparison

Compare ZVRA & INN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • INN
  • Stock Information
  • Founded
  • ZVRA 2006
  • INN 2010
  • Country
  • ZVRA United States
  • INN United States
  • Employees
  • ZVRA N/A
  • INN N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • INN Real Estate Investment Trusts
  • Sector
  • ZVRA Health Care
  • INN Real Estate
  • Exchange
  • ZVRA Nasdaq
  • INN Nasdaq
  • Market Cap
  • ZVRA 481.7M
  • INN 490.4M
  • IPO Year
  • ZVRA 2015
  • INN 2011
  • Fundamental
  • Price
  • ZVRA $12.34
  • INN $5.61
  • Analyst Decision
  • ZVRA Strong Buy
  • INN
  • Analyst Count
  • ZVRA 9
  • INN 0
  • Target Price
  • ZVRA $23.25
  • INN N/A
  • AVG Volume (30 Days)
  • ZVRA 1.0M
  • INN 3.4M
  • Earning Date
  • ZVRA 08-12-2025
  • INN 08-05-2025
  • Dividend Yield
  • ZVRA N/A
  • INN 5.75%
  • EPS Growth
  • ZVRA N/A
  • INN N/A
  • EPS
  • ZVRA N/A
  • INN 0.20
  • Revenue
  • ZVRA $40,588,000.00
  • INN $728,119,000.00
  • Revenue This Year
  • ZVRA $292.31
  • INN $2.92
  • Revenue Next Year
  • ZVRA $78.65
  • INN $2.49
  • P/E Ratio
  • ZVRA N/A
  • INN $27.48
  • Revenue Growth
  • ZVRA 46.47
  • INN N/A
  • 52 Week Low
  • ZVRA $5.45
  • INN $3.57
  • 52 Week High
  • ZVRA $12.55
  • INN $7.22
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 84.06
  • INN 69.60
  • Support Level
  • ZVRA $8.58
  • INN $5.27
  • Resistance Level
  • ZVRA $12.37
  • INN $5.62
  • Average True Range (ATR)
  • ZVRA 0.51
  • INN 0.21
  • MACD
  • ZVRA 0.31
  • INN 0.03
  • Stochastic Oscillator
  • ZVRA 98.47
  • INN 98.19

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About INN Summit Hotel Properties Inc.

Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The firm's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.

Share on Social Networks: